The Federal Ministry of Research wants to fund three German companies in the development of a vaccine against the corona virus. The companies offer “promising approaches” in vaccine development, said Federal Research Minister Anja Karliczek (CDU) in Berlin on Wednesday.
The funds from the 750 million euro special program should accelerate the work on the vaccines. The funding goes to the companies BioNTech from Mainz, CureVac from Tübingen and IDT Biologika from Dessau.
In return, the federal government expects “That an appropriate proportion of the production of an approved vaccine will be made available for needs-based care in Germany,” said Karliczek . The Federal Ministry of Health is closely involved in this process. The funding is intended to expand production capacities and increase clinical trial capacities.
Vaccines could be earliest in the middle 2021 are available
“All citizens who want to be vaccinated should be given the opportunity,” said Karliczek further. The minister warned of setbacks despite the fact that research is underway at high pressure on a vaccine.
[Lesen Sie zu dem Thema auch: Diese 23 Impfstoffkandidaten werden erprobt sowie: So weit sind die wichtigsten Impfstoffkandidaten.]
“Therefore we may do not expect any miracles and still have to assume that vaccines will not be available to the general public until the middle of next year at the earliest, “said Karliczek . She called for further compliance with the corona rules so that the virus could not spread again over a large area.
An independent one Scientific advisory board chaired by Klaus Cichutek from the Paul Ehrlich Institute recommended the three projects for funding. The minister announced “intensive talks” with the companies in the coming weeks for the precise arrangement of the funding. (AFP)